Balyasny Asset Management LLC Harrow Health, Inc. Transaction History
Balyasny Asset Management LLC
- $54.8 Billion
- Q1 2024
A detailed history of Balyasny Asset Management LLC transactions in Harrow Health, Inc. stock. As of the latest transaction made, Balyasny Asset Management LLC holds 25,953 shares of HROW stock, worth $542,158. This represents 0.0% of its overall portfolio holdings.
Number of Shares
25,953Holding current value
$542,158% of portfolio
0.0%Shares
3 transactions
Others Institutions Holding HROW
# of Institutions
123Shares Held
21.3MCall Options Held
113KPut Options Held
366K-
Opaleye Management Inc. Boston, MA3.92MShares$81.9 Million12.62% of portfolio
-
Private Capital Management, LLC Naples, FL3.01MShares$62.9 Million4.93% of portfolio
-
Black Rock Inc. New York, NY2.18MShares$45.6 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.83MShares$38.2 Million0.0% of portfolio
-
Morgan Stanley New York, NY953KShares$19.9 Million0.0% of portfolio
About HARROW HEALTH, INC.
- Ticker HROW
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 27,070,000
- Market Cap $565M
- Description
- Harrow Health, Inc. operates as an ophthalmic-focused healthcare company. The company owns ImprimisRx, an ophthalmology outsourcing and pharmaceutical compounding business; and DEXYCU for the treatment of post-operative inflammation. The company also holds equity interests in Surface Ophthalmics, Inc., a clinical-stage pharmaceutical company tha...